Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2026-01-03 @ 11:59 PM
Study NCT ID:
NCT02710604
Status:
COMPLETED
Last Update Posted:
2017-09-13
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2, Multiple Ascending Dose Proof of Concept Study
Sponsor:
ContraVir Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
None
Primary Completion Date:
2017-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-14
First Submit QC Date:
None
Study First Post Date:
2016-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-12
Last Update Post Date:
2017-09-13
Last Update Post Date Type:
ACTUAL